{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:21:44Z","timestamp":1773080504974,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Background: Evans syndrome is a rare autoimmune disease characterized by immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and autoimmune neutropenia, typically triggered by an episode of immune dysregulation or multiple other factors. We present what appears to be the first reported case of Evans syndrome developing in a 66-year-old female following respiratory syncytial virus (RSV) vaccination. Case Presentation: A 66-year-old female presented with a petechial rash on her arms, legs, and face. Laboratory tests revealed a platelet count of 1 \u00d7 109\/L, significantly lower than her historical baseline of &gt;200 \u00d7 109\/L. On hospital day 4, her hemoglobin declined from 14.3 g\/dL to 9.9 g\/dL, with laboratory evidence of hemolysis, including elevated bilirubin, low haptoglobin, and increased lactate dehydrogenase (LDH). Bone marrow biopsy revealed megakaryocytic hyperplasia consistent with ITP, along with a small polyclonal B-cell population lacking CD20 expression. Imaging was unremarkable, showing no interval changes aside from stable pre-existing pulmonary nodules and no lymphadenopathy. These findings supported a diagnosis of Evans syndrome. Initial therapy with dexamethasone and intravenous immunoglobulin (IVIG) for presumed ITP was ineffective. Due to refractory thrombocytopenia, the patient initially received one dose of rituximab, followed by one dose of romiplostim. Subsequently, the patient received rituximab infusions every week at a rate of 375 mg\/m2 for four doses, as well as prednisone at a dose of 1 mg\/kg\/day. Within five weeks, her blood count returned to normal. Conclusions: This case raises concern for a potential temporal association between RSV vaccination and the onset of Evans syndrome. It underscores the need for heightened clinical awareness and further investigation into immune-mediated hematologic complications following RSV immunization.<\/jats:p>","DOI":"10.3390\/hematolrep17060068","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:35:17Z","timestamp":1764956117000},"page":"68","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Double Trouble: The First Reported Case of Evans Syndrome Following RSV Vaccination"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-0252","authenticated-orcid":false,"given":"Mohammad","family":"Abu-Tineh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Reading Hospital-Tower Health, West Reading, PA 19611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Beereddy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Reading Hospital-Tower Health, West Reading, PA 19611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse Ivonne","family":"Saldivar Ruiz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Reading Hospital-Tower Health, West Reading, PA 19611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5365-7299","authenticated-orcid":false,"given":"Divya","family":"Samat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Reading Hospital-Tower Health, West Reading, PA 19611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPH.0000000000000897","article-title":"Natural history, pathogenesis, and treatment of Evans syndrome in children","volume":"39","author":"Mantadakis","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ajh.25574","article-title":"Evans syndrome in adults\u2014Incidence, prevalence, and survival in a nationwide cohort","volume":"94","author":"Hansen","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mannering, N., Hansen, D.L., and Frederiksen, H. (2020). Evans syndrome in children below 13 years of age: A nationwide population-based cohort study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231284"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12185-021-03243-2","article-title":"New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination","volume":"115","author":"Hidaka","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.jemermed.2012.01.060","article-title":"A case of Evans\u2019 syndrome following influenza vaccine","volume":"44","author":"Shlamovitz","year":"2013","journal-title":"J. Emerg. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3855\/jidc.17719","article-title":"Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: Case report and literature review","volume":"17","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_9","first-page":"e26602","article-title":"Evans syndrome presenting as an atypical complication of SARS-CoV-2 vaccination","volume":"14","author":"Farina","year":"2022","journal-title":"Cureus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.4081\/dr.2022.9470","article-title":"Evans\u2019 syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma","volume":"14","author":"Gambichler","year":"2022","journal-title":"Dermatol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00277-022-05034-z","article-title":"New-onset Evans syndrome in a patient with SLE post SARS-CoV-2 mRNA vaccination","volume":"102","author":"Ng","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Anastassopoulou, C., Medi\u0107, S., Ferous, S., Boufidou, F., and Tsakris, A. (2025). Development, current status, and remaining challenges for respiratory syncytial virus vaccines. Vaccines, 13.","DOI":"10.3390\/vaccines13020097"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2550857","DOI":"10.1080\/21645515.2025.2550857","article-title":"Post-marketing safety monitoring of RSV vaccines: A real-world study based on VAERS","volume":"21","author":"Bao","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.2021012924","article-title":"T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome","volume":"139","author":"Kumar","year":"2022","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Knudson, C.J., Hartwig, S.M., Meyerholz, D.K., and Varga, S.M. (2015). RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T-cell subsets. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004757"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"Openshaw","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0264-410X(01)00301-2","article-title":"Immunopathogenesis of vaccine-enhanced RSV disease","volume":"20","author":"Openshaw","year":"2001","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.00017-08","article-title":"Human genetic factors and RSV disease severity","volume":"21","author":"Miyairi","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2026","DOI":"10.1002\/rmv.2026","article-title":"Disease severity in RSV infection: Role of host genetic variation","volume":"29","author":"Tahamtan","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Miano, M., Guardo, D., Grossi, A., Palmisani, E., Fioredda, F., Terranova, P., Cappelli, E., Lupia, M., Traverso, M., and Dell\u2019Orso, G. (2022). Underlying inborn errors of immunity in patients with Evans syndrome and multilineage cytopenias: A single-centre analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.869033"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/ejh.13600","article-title":"Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation","volume":"106","author":"Grimes","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/MPH.0000000000000880","article-title":"Evans syndrome as first manifestation of primary immunodeficiency in clinical practice","volume":"39","author":"Giner","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e258322","DOI":"10.1001\/jamanetworkopen.2025.8322","article-title":"Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older","volume":"8","author":"Fry","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2500\/aap.2023.44.230030","article-title":"The third pandemic: The RSV landscape and specific considerations for the allergist\/immunologist","volume":"44","author":"Frenkel","year":"2023","journal-title":"Allergy Asthma Proc."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ferlito, C., Nisini, R., Caporuscio, S., Biondo, M.I., Germano, V., Salerno, G., Lulli, P., Picchianti Diamanti, A., Falco, M., and Biselli, V. (2021). Safety of multiple vaccinations and durability of vaccine-induced antibodies in an Italian military cohort 5 years after immunization. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010006"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/6\/68\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:22:53Z","timestamp":1764958973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/6\/68"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["hematolrep17060068"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep17060068","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}